1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NIH Common Fund Bridge2AI (Bridge to Artificial Intelligence) Program - Stage 2 is sponsored by National Institutes of Health (NIH) Common Fund. Bridge2AI is a flagship NIH program to build AI-ready biomedical datasets and ethical frameworks. Stage 2 shifts focus from dataset creation to delivering deployable tools for specific health challenges.
Universities that built infrastructure under Stage 1 are well-positioned for continuations, but new applications aligning with AI-driven biomedical research, including imaging, could be relevant.
Get alerted about grants like this
Get emailed when new opportunities from “National Institutes of Health (NIH) Common Fund” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Institutions that built infrastructure under Stage 1 are well-positioned; new applications are expected to be open to academic institutions. Confirm the full requirements in the official notice before applying.
NIH Common Fund Bridge2AI (Bridge to Artificial Intelligence) Program - Stage 2 is funded by National Institutes of Health (NIH) Common Fund. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
NIH Director's Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional) (RFA-RM-27-003) is sponsored by National Institutes of Health (NIH) Common Fund. This award supports individual scientists or groups proposing bold, groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new paradigms in infectious biology and beyond.
NIH Director's New Innovator Award (DP2) is sponsored by National Institutes of Health (NIH) Common Fund. The NIH Director's New Innovator Award, part of the High-Risk, High-Reward Research program, supports early-career investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the NIH mission. This award explicitly does not require preliminary data and encourages risky, transformative ideas. Research areas relevant to AI are included.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleAvoid common NIH grant proposal mistakes including vague specific aims, weak methodology, and poor budget justification that lead to rejection.
Read articleThe NIH Director's New Innovator Award (DP2, RFA-RM-27-002) closes August 17, 2026, offering roughly 30 Early Stage Investigators up to $475,000 in direct costs a year for five years — $2.375 million total — to pursue bold ideas without the preliminary data a standard R01 demands. Here is how the High-Risk, High-Reward program actually evaluates applications, who qualifies, and why the usual R01 instincts will sink you.
Read article